Retinai

BSI has certified our platform RetinAI Discovery and 3 of our #AI models under the Medical Devices Regulation EU 2017/745! This certification underscores our commitment to excellence and compliance with the highest industry standards. What this means:  👉 Our quality management system met the rigorous requirements of the EU Medical Device Regulation (EU) 2017/745, ensuring top-tier safety and effectiveness. 👉 Our advanced ophthalmology assessment and diagnostic support technologies, including RetinAI's AI models for Macula Biomarkers, Layer Segmentation and Fluid Segmentation models, have been validated and recognized to meet a healthcare need. 👉 With this certification, we strengthen our position as a trusted pioneer in the AI healthcare technology space. This milestone is a testament to our team's dedication and the robust quality systems we have in place. Thank you to our team, partners, and clients for their unwavering support. Together, we are shaping the future of eye care! For more information, read the press release 👉 https://lnkd.in/ecsjmHQW #MDRCertification #AIinHealthcare #Innovation #QualityAssurance #HealthcareTech Ikerian

Adel Bencheikh, Director Eye Care at Canon Medical Systems Europe, foresees a transformative decade ahead for retina healthcare driven by AI. From refining manufacturing to enhancing clinical screenings, the journey is unfolding now. What changes do you anticipate AI will bring to retina healthcare in the next 5-10 years? Share your thoughts below! Access the full conversation on our blog: https://lnkd.in/evmg7YVG #AI #Ophthalmology #RetinaHealthcare 

Our platform #Discovery accelerates R&D and lays the foundation of Digital Precision Medicine! Discovery provides vendor neutral image & data management at-scale (Imaging, EMR, Gene markers, Annotations), advanced #AI analysis and #automation pipelines for complex and large datasets. Our AI models generate powerful insights to gather biomarker & clinical endpoint data on OCT, FAF & Fundus images. Accelerate & enrich your data analysis and R&D with: 👉 A single data platform to manage & access your data anytime from anywhere 👉 CE-marked and research use only AI models to extract insights about disease progression, treatment outcomes & progression prediction 👉 Global collaboration and participative research enabled through a secured cloud-based access to data. RetinAI Discovery is ready to enable the right decisions sooner for your R&D drug pipeline. Get in touch with us, and see how Discovery can help you 👉 https://lnkd.in/e2Crt9Ah #clinicalresearch #datamanagement #datanalysis #drugdiscovery #drugdevelopment #precisionmedicine #digitalhealth #healthcare #ophthalmology #eyecare #retina #artificialintelligence #machinelearning 

Traditional patient-reported outcomes often fall short in capturing the complexity of #retinal diseases. That's why we're shifting the focus to structural #endpoints — quantifiable changes measured through advanced imaging and #AI. In our latest blog, we explore how AI-powered evaluation of structural endpoints is revolutionizing the management of conditions like neovascular Age-related Macular Degeneration (#nAMD), Geographic Atrophy (#GA), and Central Serous Chorioretinopathy (#CSC). Discover how these advancements: 🔬 Enhance precision in disease monitoring 📈 Provide objective, consistent data 💡 Empower personalized treatment strategies Read the full article to learn how RetinAI Discovery is at the forefront of this transformative approach 👉 https://lnkd.in/eyu-RZKZ #Ophthalmology #AI #HealthcareInnovation #RetinalDisease #ClinicalTrials #MedicalResearch Léa Errog

The RetinAI team is all set for ASRS – American Society of Retina Specialists annual meeting in Stockholm next week! We are excited to connect once again with world leaders in ophthalmology this July and share our latest advancements in #eyecare. Join us to discover how our solutions are shaping the future of #ophthalmology, #digitalhealth, and #AI. Meet us in Stockholm and get a personalized demo from our team: Natasa Jovic, B.Sc., MBA, Aunia Grogan, and Carlos Ciller. We are eager to discuss how we can empower your Pharma, Clinics, and Research initiatives. 📅 Want to have a one-on-one discussion? Schedule a meeting with us in advance here: https://lnkd.in/ej2QMxzn We can't wait to meet you there and dive into the world of #precisionmedicine, #AI and #Eyecare innovation.

At RetinAI, we are committed to providing responsive, innovative, and collaborative solutions that drive new insights and strengthen our partnerships. 🌟 Our dedication has led to continued success across multiple projects, empowering our partners in eye care. Thank you, Lori H., for your kind words! Discover more about how we're transforming the future of eye care for Life Sciences & Pharma companies 👉 https://lnkd.in/ewVNUpUC #EyeCareInnovation #Partnership #ClinicalInsights #RetinAI

Ready to embark on a new adventure with us? Check out the detailed job descriptions and submit your application. We can't wait to see what you bring to our team!!

How retinal biomarkers are revolutionizing the detection of neurodegenerative diseases like Alzheimer's and Parkinson’s? Early stages of diseases like MS, Alzheimer’s, and Parkinson's can be detected on OCTs, showing subtitle yet critical changes. Our platform Discovery, powered by our AI models, can detect those minute changes providing a support for earlier diagnostics, potentially altering treatment outcomes. Read our blog for more about the cutting-edge approach to neurology through the lens of ophthalmology 👉 https://lnkd.in/eTbtYVaq #Innovation #HealthTech #EyeHealth Ikerian Romina Lasagni Vitar, PhD

On Monday, some of our Retinauts gathered for a fantastic barbecue party under the sunny skies of Switzerland's beautiful capital 😎 From exciting games to the Rodelbahn ride, the day was filled with fun and laughter. Our team showed that work and play can blend perfectly! A big shoutout to our Swiss-based team for organizing such a memorable event. We can't wait for the next adventure! #TeamBuilding #Retinauts #SwissAdventures #WorkHardPlayHard #CompanyCulture #BernFun

Only 1 week left! Meet Aunia Grogan, our VP Business Development at the 2nd Annual Retinal Imaging Biomarkers & Endpoints Summit in Boston from June 25 to 27. Aunia looks forward to joining this exciting forum and connecting with leading retinal experts like you! Schedule your meeting with Aunia to get an overview of our solutions 👉 https://lnkd.in/e5U7kk2Y See you in Boston!